My last two newsletters have examined COVID 19’s lethality in England and Europe, respectively. This newsletter examines the disease’s lethality in the United States. As my previous newsletters noted, the two most widely discussed methods for quantifying COVID-19’s lethality – estimating the IFR and calculating the “excess deaths” – may not be very reliable. (Please read the first three paragraphs